部分客户文章列表
1. (IF=29.983) Li L, Fu W, Gong X, et al. The role of G protein-coupled receptor kinase 4 in cardiomyocyte injury after myocardial infarction[J]. European Heart Journal, 2021, 42(14): 1415-1430.
2. (IF=27.287) Ji Y X, Wang Y, Li P L, et al. A kinome screen reveals that Nemo-like kinase is a key suppressor of hepatic gluconeogenesis[J]. Cell Metabolism, 2021, 33(6): 1171-1186. e9.
3. (IF=25.617) Fu Z, Zhang X, Zhou X, et al. In vivo self-assembled small RNAs as a new generation of RNAi therapeutics[J]. Cell research, 2021, 31(6): 631-648.
4. (IF=25.617) Fu G B, Huang W J, Zeng M, et al. Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens[J]. Cell research, 2019, 29(1): 8-22.
5. (IF=12.27) Zou Y, Wang A, Huang L, et al. Illuminating NAD+ metabolism in live cells and in vivo using a genetically encoded fluorescent sensor[J]. Developmental cell, 2020, 53(2): 240-252. e7.
6. (IF=11.981) Jiang H, Jia D, Zhang B, et al. Exercise improves cardiac function and glucose metabolism in mice with experimental myocardial infarction through inhibiting HDAC4 and upregulating GLUT1 expression[J]. Basic Research in Cardiology, 2020, 115(3): 1-16.
7. (IF=10.717) Zhang Y, Xue W, Zhang W, et al. Histone methyltransferase G9a protects against acute liver injury through GSTP1[J]. Cell Death & Differentiation, 2020, 27(4): 1243-1258.
8. (IF=10.122) Ma X, Zhou Z, Chen Y, et al. RBP4 functions as a hepatokine in the regulation of glucose metabolism by the circadian clock in mice[J]. Diabetologia, 2016, 59(2): 354-362.
9. (IF=9.461) Zhang W, Yang D, Yuan Y, et al. Muscular G9a regulates muscle-liver-fat axis by musclin under overnutrition in female mice[J]. Diabetes, 2020, 69(12): 2642-2654.
10. (IF=8.579) Li Y, Chen M, Zhou Y, et al. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease[J]. Theranostics, 2020, 10(8): 3579.
11. (IF=8.579) Yu W, Sun S, Xu H, et al. TBC1D15/RAB7-regulated mitochondria-lysosome interaction confers cardioprotection against acute myocardial infarction-induced cardiac injury[J]. Theranostics, 2020, 10(24): 11244.
12. (IF=8.469) Zheng Z, Li Y, Fan S, et al. WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1[J]. Cell death & disease, 2021, 12(3): 1-16.
13. (IF=8.460) Liu D, Tian X, Liu Y, et al. CREG ameliorates the phenotypic switching of cardiac fibroblasts after myocardial infarction via modulation of CDC42[J]. Cell death & disease, 2021, 12(4): 1-16.
14. (IF=6.832) Zheng D, Zhou H, Wang H, et al. Mesenchymal stem cell-derived microvesicles improve intestinal barrier function by restoring mitochondrial dynamic balance in sepsis rats[J]. Stem Cell Research & Therapy, 2021, 12(1): 1-21.
15. (IF=6.831) Shao C, Yang X, Jing Y, et al. The stemness of hepatocytes is maintained by high levels of lipopolysaccharide via YAP1 activation[J]. Stem cell research & therapy, 2021, 12(1): 1-17.
病毒载体比较

AAV
和元生物生产的每一个rAAV都经历数十道工序的锤炼,随机检测的rAAV空壳率<2%、内毒素<2.5EU/mL;同时,每批rAAV产品在出库前均会进行多轮滴度测定,保证产品的滴度准确,更好地指导实验研究。此外,我们使用大规模GMP级病毒包装质粒,用于研究级rAAV病毒载体的生产,全力减少批次间差异,降低杂质及污染,让基因递送触手可及!
AAV中包 总量1.0E+12 v.g., 滴度≥1.0E+12 v.g./mL | 病毒包装3980元/个;过表达全套6800元/套; 干扰定制(单靶点)4980元/个 |
AAV大包 总量5.0E+12 v.g., 滴度≥5.0E+12 v.g./mL | 病毒包装5980元/个;过表达全套8800元/套; 干扰定制(单靶点)6980元/个 |
AAV超大包 总量1.0E+13 v.g., 滴度≥1.0E+13 v.g./mL | 病毒包装7980元/个;过表达全套10800元/套; 干扰定制(单靶点)8980元/个 |
注:1、基因3kb以内,不超载; 2、病毒包装:质粒抽提+病毒包装+滴度检测; 3、过表达全套:基因合成+载体构建+质粒抽提+表达检测+病毒包装+滴度检测+对照病毒(仅限库存对照); 4、干扰定制(单靶点):载体构建+质粒抽提+病毒包装+滴度检测+对照病毒(仅限库存对照)。
慢病毒
和元生物生产的每一个慢病毒颗粒都经历数十道工序的锤炼、经历多轮滴度测定,我们使用大规模GMP级病毒包装质粒,用于研究级慢病毒载体的生产,全力减少批次间差异,降低杂质及污染,让基因递送触手可及!
慢病毒中包 1.0E+8TU (基因3kb以内) | 过表达全套3980元/套 基因合成+载体构建+质粒抽提+病毒包装+滴度检测+对照病毒(仅限库存对照) |
干扰定制(单靶点)1980元/套 载体构建+质粒抽提+病毒包装+滴度检测+对照病毒(仅限库存对照) |
干扰全套5800元/套 载体构建+质粒抽提+病毒包装+滴度检测+对照病毒(仅限库存对照) |
让基因递送触手可及!
Make Gene Delivery Accessible.

病毒相关技术服务:
病毒包装服务 腺相关病毒包装 慢病毒包装 腺病毒包装 逆转录病毒包装